Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices - PubMed (original) (raw)

Review

Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices

T R Moench et al. AIDS. 2001.

No abstract available

PubMed Disclaimer

Similar articles

• Female controlled methods of contraception and sexually transmitted infections including HIV in Malawi: examining the role of the female condom and microbicides.
  Bisika T. Bisika T. East Afr J Public Health. 2009 Aug;6(2):223-5. doi: 10.4314/eajph.v6i2.51791. East Afr J Public Health. 2009. PMID: 20000034 No abstract available.
• The slow evolution of microbicides for STD/HIV prevention.
  Howes J, Bass M. Howes J, et al. J Gend Specif Med. 1999 May-Jun;2(3):22-3. J Gend Specif Med. 1999. PMID: 11252848 No abstract available.
• The design of prophylactic trials for HIV: the case of microbicides.
  Stein ZA, Myer L, Susser M. Stein ZA, et al. Epidemiology. 2003 Jan;14(1):80-3; discussion 83-4. doi: 10.1097/00001648-200301000-00018. Epidemiology. 2003. PMID: 12500050 No abstract available.
• Observations from the CDC. The urgent need for new HIV/STD prevention options for women.
  Irwin K, Scarlett M, Moseley R. Irwin K, et al. J Womens Health. 1998 Nov;7(9):1081-6. doi: 10.1089/jwh.1998.7.1081. J Womens Health. 1998. PMID: 9861583 Review. No abstract available.
• Specific microbicides in the prevention of HIV infection.
  Kelly CG, Shattock RJ. Kelly CG, et al. J Intern Med. 2011 Dec;270(6):509-19. doi: 10.1111/j.1365-2796.2011.02454.x. Epub 2011 Oct 27. J Intern Med. 2011. PMID: 21917029 Review.

Cited by

• Systems analysis reveals differential expression of endocervical genes in African women randomized to DMPA-IM, LNG implant or cu-IUD.
  Gupta PM, Balle C, Tharp GK, Nelson SA, Gasper MA, Brown B, Alisoltani A, Onono M, Palanee-Phillips T, Nair G, Ayele H, Noel-Romas L, Passmore JS, Burgener AD, Heffron R, Jaspan HB, Bosinger SE. Gupta PM, et al. Clin Immunol. 2023 Oct;255:109750. doi: 10.1016/j.clim.2023.109750. Epub 2023 Sep 3. Clin Immunol. 2023. PMID: 37660744 Free PMC article. Clinical Trial.
• Systems Analysis Reveals Contraceptive-Induced Alteration of Cervicovaginal Gene Expression in a Randomized Trial.
  Balle C, Gupta PM, Tharp GK, Nelson SA, Konstantinus IN, Lennard K, Jaumdally SZ, Happel AU, Barnabas SL, Gill K, Bekker LG, Passmore JS, Jaspan HB, Bosinger SE. Balle C, et al. Front Reprod Health. 2022 Mar 3;4:781687. doi: 10.3389/frph.2022.781687. eCollection 2022. Front Reprod Health. 2022. PMID: 36303659 Free PMC article.
• Lactate Suppresses Retroviral Transduction in Cervical Epithelial Cells through DNA-PKcs Modulation.
  Wagner W, Sobierajska K, Kania KD, Paradowska E, Ciszewski WM. Wagner W, et al. Int J Mol Sci. 2021 Dec 7;22(24):13194. doi: 10.3390/ijms222413194. Int J Mol Sci. 2021. PMID: 34947988 Free PMC article.
• Design of Poly(lactic-_co_-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis.
  Yang H, Li J, Patel SK, Palmer KE, Devlin B, Rohan LC. Yang H, et al. Pharmaceutics. 2019 Apr 16;11(4):184. doi: 10.3390/pharmaceutics11040184. Pharmaceutics. 2019. PMID: 30995761 Free PMC article.
• Incidence of sexually transmitted infections during pregnancy.
  Teasdale CA, Abrams EJ, Chiasson MA, Justman J, Blanchard K, Jones HE. Teasdale CA, et al. PLoS One. 2018 May 24;13(5):e0197696. doi: 10.1371/journal.pone.0197696. eCollection 2018. PLoS One. 2018. PMID: 29795625 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Medical

  • MedlinePlus Health Information